Skip to main content
. 2023 Jun 2;10:1128195. doi: 10.3389/fcvm.2023.1128195

Table 2.

Summary of main genetic and molecular pathway alterations associated with non-syndromic mitral valve prolapse.

Occurrence Genes Proteins Function
Familial Autosomal dominant
  • - 

    MMVP1

  • - 

    MMVP2

  • - 

    MMVP3

  • - 

    DCHS1

  • - 

    Protein dachsous homolog 1

  • - 

    Cadherin: cell-to-cell adhesion for tissue morphogenesis and homeostasis

X-linked
  • - 

    FLNA

  • - 

    Filamin A

  • - 

    MAPK3 and MAP2K1 activation for mitral valve tissue proliferation

Sporadic
  • - 

    DCHS1

  • - 

    Protein dachsous homolog 1

  • - 

    Cadherin: cell-to-cell adhesion for tissue morphogenesis and homeostasis

  • - 

    DZIP1

  • - 

    DAZ interacting Zinc finger protein

  • - 

    Cilium assembly

  • - 

    FLNC

  • - 

    Filamin C

  • - 

    Cell-to-cell adhesion

  • - 

    MMP-3

  • - 

    Matrix metalloproteinase-3

  • - 

    ECM remodeling

  • - 

    FBN1

  • - 

    Fibrillin-1

  • - 

    Decrease binding of TGF-β binding proteins

  • - 

    COL3A1

  • - 

    Collagen type III α1 chain

  • - 

    ECM structural protein for tissue resistance

  • - 

    LIM

  • - 

    Protein interaction domain

  • - 

    Cell migration regulation

  • - 

    LMCD1

  • - 

    LIM and cysteine-rich domains protein

  • - 

    Cell migration regulation

  • - 

    TNS1

  • - 

    Tensin 1

  • - 

    Cell adhesion control

  • - 

    GLIS1

- Glis family Zinc finger 1
  • - 

    Transcription factor involved in cell reprogramming and proliferation

  • - 

    LTBP2

  • - 

    Latent TGF-b binding protein 2

  • - 

    ECM protein

  • - 

    TGFB2

  • - 

    TGF-b 2

  • - 

    ECM protein

  • - 

    ALPK3

  • - 

    Alpha kinase 3

  • - 

    Myocyte hypertrophy

ECM, extracellular matrix; TGF-β, transforming growth factor-beta.